Support Muscle Health and Promote a Healthier Body Composition
As the most common GLP-1 side effect, digestive issues must be addressed to improve quality of life.
Up to 40% of weight loss associated with GLP-1 use may come from muscle loss.1
The global GLP-1 support supplements market was valued at $1.24B in 2024 and is projected to reach $3.41B by 2033, growing at a CAGR of 11.8%.3
Muscle mass was significantly enhanced in aged mice after 8 weeks of supplementation, with the calf (tibialis anterior) and thigh (quadriceps femoris) muscles increasing by 53% and 34%, respectively.
Muscle cross-sectional area increased by 8.2% in aged mice following 8 weeks of supplementation, indicating enhanced muscle size.
Proteases break down proteins into absorbable molecules, improving digestion.
Protease activity in the intestine increased by 1.89-fold after 8 weeks, indicating more efficient protein digestion and utilization.
Muscle mass and size were increased in aged mice after 8 weeks of supplementation, without changing body weight or food intake, indicating improved body composition and increased muscle proportion without altering existing dietary habits.
The recommended dose of MyoGastro™ for a healthy adult is one unit daily according to specific requirements.
Benefits of MyoGastro™ for Muscle Health:
Your Target Audience Who Are
GLP-1 users seeking to maintain lean body mass
Individuals focused on weight management while building lean muscle
Regular exercisers aiming to maintain and enhance muscle condition
Market-Ready Formula Concepts
The Scientifically Proven, Market-Ready Solution to Set Your Products Apart and
Accelerate Your Success
XtraMyo™ PRODUCT CONCEPTS
Ingredient:
Vigiis 101-LAB
Application:
Supports Healthy Blood Lipid Levels*
Promotes Healthy Cholesterol Levels Already Within Normal Range*
Supports Cardiovascular Health*
Vigiis 101-LAB PRODUCT CONCEPTS
Ingredient:
Vigiis 101-LAB
Application:
Supports body balance*
Enhances gut microbiome health*
Promotes healthy digestion*
Helps boost metabolism*
The communication is intended for business-to-business information and not for the final consumer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.